Department of Neurology, Peking University First Hospital, 8 Xishiku Street, Xicheng District, Beijing 100034, China.
Department of Neurology, Peking University First Hospital, 8 Xishiku Street, Xicheng District, Beijing 100034, China.
Neuromuscul Disord. 2018 Aug;28(8):646-651. doi: 10.1016/j.nmd.2018.05.003. Epub 2018 May 15.
Autosomal recessive axonal neuropathy with neuromyotonia (ARANNM) is a rare disease caused by mutations of histidine triad nucleotide binding protein 1 (HINT1) gene. ARANNM has been reported mainly in European countries but little reported so far in China. We describe novel mutations of HINT1 in three Chinese patients with ARANNM from unrelated families. Patient 1 was a 14-year-old girl who presented with progressive distal weakness of upper limbs at two years of age. After that, she reported weakness of both feet, and difficulty in muscle relaxation after making a fist. Patient 2 was an 18-year-old boy, who presented with progressive distal weakness of all limbs with foot drop at the age of ten with loss of ambulation at age 15. Patient 3 was a 26-year-old man who had been afflicted with weakness and atrophy of distal lower limbs since the age of 16 complaining about muscle stiffness of the lower limbs when standing and walking, and contraction of finger flexion muscles when releasing a forced grip. Electrodiagnostic testing revealed an axonal motor or sensorimotor neuropathy with or without myokymic discharges. Sural biopsy showed no pathological changes in patient 1 and mild axonal neuropathies with demyelination in patients 2 and 3. Genetic analysis revealed HINT1 with novel compound heterozygous c.112T > C (p.C38R) and c.171G > C (p.K57N) mutations in patient 1, homozygous c.112T > C (p.C38R) mutation in patient 2, as well as compound heterozygous c.112T > C (p.C38R) and c.98T > C (p.F33S) mutations in patient 3. Our study, for the first time, confirms ARANNM in the Chinese population. These genetic findings can help expand the genotypic spectrum of HINT1 mutations.
常染色体隐性遗传性运动感觉神经病伴肌强直(ARANNM)是一种由组氨酸三联体核苷酸结合蛋白 1(HINT1)基因突变引起的罕见疾病。ARANNM 主要在欧洲国家报道,但迄今为止在中国报道甚少。我们描述了来自三个无血缘关系家庭的 3 例中国 ARANNM 患者的 HINT1 新突变。患者 1 为 14 岁女孩,2 岁时出现进行性上肢远端肌无力,此后出现双脚无力,握拳后肌肉松弛困难。患者 2 为 18 岁男孩,10 岁时出现四肢进行性远端无力伴足下垂,15 岁时丧失行走能力。患者 3 为 26 岁男性,自 16 岁起下肢远端无力和萎缩,下肢站立和行走时肌肉僵硬,用力握拳时手指屈肌收缩。电诊断检查显示为轴索性运动或感觉运动神经病,伴或不伴肌纤维颤动放电。腓肠神经活检显示患者 1 无明显病理改变,患者 2 和 3 为轻度轴索性神经病伴脱髓鞘。基因分析显示患者 1 存在 HINT1 复合杂合突变 c.112T>C(p.C38R)和 c.171G>C(p.K57N),患者 2 存在纯合突变 c.112T>C(p.C38R),患者 3 存在 HINT1 复合杂合突变 c.112T>C(p.C38R)和 c.98T>C(p.F33S)。本研究首次在中国人中证实了 ARANNM 的存在。这些遗传发现可以帮助扩展 HINT1 突变的基因型谱。